Origin Therapeutics Holdings (XCNQ:ORIG) Equity-to-Asset : 0.97 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Origin Therapeutics Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was C$3.08 Mil. Origin Therapeutics Holdings's Total Assets for the quarter that ended in Jun. 2023 was C$3.19 Mil.

The historical rank and industry rank for Origin Therapeutics Holdings's Equity-to-Asset or its related term are showing as below:

XCNQ:ORIG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.93 Med: 0.97 Max: 0.98
Current: 0.97

During the past 2 years, the highest Equity to Asset Ratio of Origin Therapeutics Holdings was 0.98. The lowest was 0.93. And the median was 0.97.

XCNQ:ORIG's Equity-to-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.58 vs XCNQ:ORIG: 0.97

Origin Therapeutics Holdings Equity-to-Asset Historical Data

The historical data trend for Origin Therapeutics Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Equity-to-Asset Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Equity-to-Asset

0.98

0.97

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Equity-to-Asset	Get a 7-Day Free Trial				0.97	0.97	0.98	0.93	0.97

Competitive Comparison of Origin Therapeutics Holdings's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Equity-to-Asset falls into.

Origin Therapeutics Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Origin Therapeutics Holdings's Equity to Asset Ratio for the fiscal year that ended in Sep. 2022 is calculated as

Equity to Asset (A: Sep. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	5.429	/	5.588
	=

Origin Therapeutics Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	3.081	/	3.191
	=

Origin Therapeutics Holdings (XCNQ:ORIG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Origin Therapeutics Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.